Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neurocysticercosis: an update.

Arturo Carpio1

  • 1School of Medicine, University of Cuenca, Cuenca, Ecuador. arcarpio@az.pro.ec

The Lancet. Infectious Diseases
|December 7, 2002
PubMed
Summary
This summary is machine-generated.

Taeniosis and cysticercosis, caused by the Taenia solium tapeworm, affect global populations. Prevention is key, especially in less developed countries, to combat these parasitic infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Etiology of active epilepsy in adults: A Latin American multicenter hospital-based study.

Seizure·2026
Same author

Reader Response: Seizures and Epilepsy in Association With Neurocysticercosis: a Nosologic Proposal.

Neurology·2026
Same author

Identification of abnormal patterns of evolution of neurocysticercosis cysts and what they might indicate.

medRxiv : the preprint server for health sciences·2025
Same author

Pediatric Neurocysticercosis. Burden of pediatric neurological disorders in resource-limited regions.

Seminars in pediatric neurology·2025
Same author

Impact of albendazole treatment on the symptom profile of neurocysticercosis patients 14-16 years following diagnosis.

Parasitology·2025
Same author

How patient, infection and cysticercus characteristics impact the evolution of <i>Taenia solium</i> larva in the human brain: A unique cyst-level analysis.

Parasitology·2025
Same journal

Nine-valent human papillomavirus vaccine: implications for cervical elimination.

The Lancet. Infectious diseases·2026
Same journal

Community-engaged implementation strategies to increase doxycycline post-exposure prophylaxis uptake among men who have sex with men in China (DoxyForward): a three-group, open-label, randomised controlled trial.

The Lancet. Infectious diseases·2026
Same journal

Efficacy, safety, and immunogenicity of an Escherichia coli-produced nine-valent human papillomavirus vaccine: a multicentre, double-blind, randomised, controlled, phase 3 trial.

The Lancet. Infectious diseases·2026
Same journal

Efficacy of WRSs2, a live-attenuated Shigella sonnei vaccine, against shigellosis in a controlled human infection model in the USA: a phase 2, double-blind, randomised, placebo-controlled trial.

The Lancet. Infectious diseases·2026
Same journal

Size of the 2026 Ebola outbreak and risk of cross-border spillover from Bundibugyo virus in Ituri Province, DR Congo, and its implications for preparedness: a recalibrated stochastic modelling study.

The Lancet. Infectious diseases·2026
Same journal

Can stochastic modelling predict cross-border spread of the Bundibugyo Ebola virus outbreak in Africa?

The Lancet. Infectious diseases·2026
See all related articles

Area of Science:

  • Parasitology
  • Infectious Diseases
  • Neurology

Background:

  • Taeniosis and cysticercosis, caused by the Taenia solium tapeworm, are global health concerns, exacerbated by migration.
  • Neurocysticercosis is the most prevalent parasitic disease affecting the human nervous system.
  • Prevalence of antibodies in endemic regions suggests widespread exposure but not necessarily active infection.

Purpose of the Study:

  • To review the diagnosis, clinical manifestations, and treatment of neurocysticercosis.
  • To highlight the importance of imaging in diagnosis and classification.
  • To emphasize prevention as a primary public health strategy.

Main Methods:

  • Diagnostic imaging (CT/MRI) is the gold standard for neurocysticercosis diagnosis.

Related Experiment Videos

  • Classification into active, transitional, and inactive forms aids clinical-imaging correlation.
  • Clinical manifestations include seizures, headaches, and neurological deficits.

    • Main Results:

    • Imaging reveals viable cysts, mural nodules, degenerative cysts, and calcifications.
    • Sequelae can include epilepsy, hydrocephalus, and dementia.
    • Parenchymal neurocysticercosis generally has a good prognosis for remission.

    Conclusions:

    • Effective treatment requires individualized patient management with various medications.
    • Anthelmintic drugs like praziquantel and albendazole are used, but optimal dosing requires further research.
    • Prevention strategies are crucial for public health, particularly in less developed nations.